|
Volumn 28, Issue 3, 2002, Pages 297-307
|
Analysis of samples from patients treated with ReFacto® for the presence of anti-SQ-peptide specific antibodies
a a
a
Biovitrum AB
*
(Sweden)
|
Author keywords
Continuous epitope; Human antibodies; Immunogenicity; ReFacto ; SQ peptide
|
Indexed keywords
EPITOPE;
MONOCLONAL ANTIBODY;
POLYPEPTIDE;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
AUTOANTIBODY;
BLOOD CLOTTING FACTOR 8;
PEPTIDE FRAGMENT;
RECOMBINANT FACTOR VIII SQ;
RECOMBINANT PROTEIN;
AMINO ACID SEQUENCE;
ANTIBODY DETECTION;
ANTIBODY SPECIFICITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HEMOPHILIA;
HEMOPHILIA A;
HUMAN;
IMMUNOGENICITY;
PEPTIDE ANALYSIS;
PLASMA;
PRIORITY JOURNAL;
SERUM;
TREATMENT OUTCOME;
ANIMAL;
BLOOD;
CASE CONTROL STUDY;
CROSS REACTION;
GENETIC LINKAGE;
GENETICS;
IMMUNOLOGY;
METHODOLOGY;
MOUSE;
ANIMAL;
ANTIBODY SPECIFICITY;
AUTOANTIBODIES;
CASE-CONTROL STUDIES;
CROSS REACTIONS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FACTOR VIII;
HEMOPHILIA A;
HUMAN;
LINKAGE (GENETICS);
MICE;
PEPTIDE FRAGMENTS;
RECOMBINANT PROTEINS;
ANIMALS;
HUMANS;
|
EID: 0036017371
PISSN: 00946176
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2002-32666 Document Type: Article |
Times cited : (6)
|
References (36)
|